GST Hits Excise-free Zones; Pharma, FMCG Cos Worried Firms petition govt after a new DIPP scheme offers them only 58% CGST reimbursement A new GST reimbursement scheme has left Dabur, Godrej and many other FMCG and pharmaceutical companies worried about their manufacturing operations in Himachal Pradesh, Uttarakhand and some northeastern states where they used to enjoy excise duty exemptions.Apprehension has set in after the department of industrial policy and promotion (DIPP) last week unveiled guidelines of a scheme that replaces the erstwhile excise-free zones, offering 58% central GST reimbursement. Companies that outsource manufacturing to job workers in these states have petitioned the government saying the new restrictions may render their businesses unviable. They are also exploring legal options.Many pharma companies including Cipla, Dr Reddy's, Johnson & Johnson and Wockhardt have plants in excise duty-free zones in Himachal Pradesh.TVS Motor, Lloyd Electric, TAFE...